By Abigail Townsend
Date: Thursday 23 Apr 2026
(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance on Thursday, despite a rise in costs following the outbreak of war in the Middle East.
| Hikma warns of slower growth, shares plunge | 26-Feb-2026 | ShareCast |
| Brookfield not planning to make an offer for Hik... | 04-Feb-2026 | ShareCast |
| Director/PDMR Shareholding | 19-Dec-2025 | ShareCast |
| Director/PDMR Shareholding | 19-Dec-2025 | ShareCast |
| Hikma chief executive steps down after two years... | 15-Dec-2025 | ShareCast |
| Director/PDMR Shareholding | 19-Dec-2025 | 15:50 | RNS |
| Director/PDMR Shareholding | 19-Dec-2025 | 15:43 | RNS |
| Hikma boosts injectables business with $300m deal | 29-May-2014 | Telegraph |
| MARKET REPORT: Shares jump as Hikma Pharmaceutic... | 08-May-2014 | Daily Mail |
| Hikma prepares return to Libya | 26-Aug-2011 | The Independent |
| Hikma deals pay off | 19-Mar-2008 | Telegraph |
| Hikma launches bid for generic drugs firm | 08-Oct-2007 | Telegraph |
| Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
| Investment Column:Hikma | 02-Feb-2011 | The Independent |
| Questor:Hikma Pharmaceuticals | 23-Jul-2008 | Telegraph |
| Market Report: Respite for Rentokil after buyout... | 18-Jan-2008 | The Independent |
| Property sector buoyed by Laxey's £1bn opportuni... | 15-Jan-2008 | Telegraph |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 1,427.00p |
| Change Today | 9.50p |
| % Change | 0.67 % |
| 52 Week High | 2,148.00 |
| 52 Week Low | 1,191.00 |
| Volume | 425,383 |
| Shares Issued | 216.15m |
| Market Cap | £3,084.48m |
| Beta | 0.00 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 19-Mar-26 | 14-Aug-25 |
| Paid | 30-Apr-26 | 18-Sep-25 |
| Amount | 48.00¢ | 36.00¢ |
| Time | Volume / Share Price |
| 14:32 | 1 @ 1,422.00p |
| 14:32 | 0 @ 1,422.00p |
| 14:32 | 0 @ 1,422.00p |
| 16:47 | 4,144 @ 1,417.24p |
| 16:35 | 196,306 @ 1,427.00p |
| CEO | Said Darwazah |
| Chair | Victoria Hull |
You are here: research